Pfizer
FDA Revises EUA for Paxlovid
The FDA announced a revision to the emergency use authorization for Paxlovid: Product manufactured and labeled in ...
FEBRUARY 21, 2024
ACIP Recommends PREVNAR 20 for Infants and Children
The CDC’s ACIP recently voted to recommend the 20-valent Pneumococcal Conjugate Vaccine for routine use to ...
JULY 19, 2023
ACIP Recommends RSV Vaccine for Adults 60 and Older After Consulting Their Healthcare Providers
The ACIP recently recommended that adults 60 and older may receive one of the new RSV vaccines following a ...
JUNE 26, 2023
FDA Approves Abrysvo RSV Vaccine for Older Adults
The FDA approved the vaccine, Abrysvo, to prevent serious RSV disease in people 60 years and older.
JUNE 1, 2023
FDA Approves Paxlovid for Treatment of COVID-19 in Adults
The FDA approved the oral antiviral Paxlovid to treat mild to moderate COVID-19 in adults who are at high risk for ...
MAY 25, 2023
FDA Advisory Committee Supports Safety and Effectiveness of Paxlovid for COVID-19
Available data support the safety and effectiveness of Paxlovid to treat mild to moderate COVID-19 in adults who ...
MARCH 17, 2023
FDA’s VRBPAC Favors Approval of Pfizer’s RSV Vaccine Candidate in Older Adults
RSV infections account for approximately 60,000 to 160,000 hospitalizations and 6,000 to 13,000 deaths each year in ...
MARCH 1, 2023
FDA Authorizes Moderna’s and Pfizer’s Bivalent COVID-19 Vaccines for Boosters in Children Ages 5+
The FDA amended the emergency use authorizations of both the Moderna and Pfizer-BioNTech bivalent COVID-19 vaccines ...
OCTOBER 12, 2022
Prescribe Paxlovid, but Know the Risks
Paxlovid reduces hospitalizations and deaths from COVID-19, so clinicians should not avoid prescribing it for mild ...
JUNE 2, 2022
ACIP Recommends 2 Vaccines for Some Travelers
The Advisory Committee on Immunization Practices (ACIP) voted to recommend two vaccines for people who travel or ...
FEBRUARY 27, 2022
COVID-19 Vaccine Mix-Ups: What Pharms Can Do
In the two months since Pfizer-BioNTech was granted an EUA for its COVID-19 vaccine in children 5 to 11 years of ...
JANUARY 20, 2022
Preliminary Data Demonstrate 3 Doses of COVID-19 Vaccine Effective Against Omicron
Three's the charm when it comes to fighting the omicron variant. Pfizer-BioNtech recommend booster doses to ...
DECEMBER 8, 2021
